Insight into human physiology is key to maintaining diver safety in underwater operational environments. Numerous hazardous physiological phenomena can occur during the descent, the time at depth, the ascent, and the hours after a dive that can have enduring consequences. While safety measures and strict adherence to dive protocols make these events uncommon, diving disorders still occur, often with insufficient understanding of the factors that triggered the event.
View Article and Find Full Text PDFObjective: To report our recent experience with prenatal detection of significant cardiovascular malformations (CVMs) in Nevada's state-wide maternal population receiving prenatal care.
Methods: We queried our databases for those with significant CVMs diagnosed pre- or postnatally between May 1, 2021, and April 30, 2024. We defined CVMs as those that required, would have required, or will likely require a therapeutic procedure in the first 12 months.
Three topics related to ANSI/HPS Standard N13.56, Sampling and Monitoring Releases of Airborne Radioactivity in the Workplace, are discussed. First, due to the omission of consideration of the activity's half-life in the standard's continuous particulate air monitor (CPAM) quantitative method, it is possible for concentration estimates produced by that calculation to be underestimated.
View Article and Find Full Text PDFThe synthesis of 2-pyridinemethanamido borohydride complexes of yttrium and neodymium was achieved through the deprotonation of the protio-ligand 2-pyridinemethanamine CHRN-C(CH)R-NH(2,6-PrCH), denoted as PyAH (with PyAH1: R = R = H; PyAH2: R = CH, R = H; PyAH3: R = C(CH)N-(2,6-PrCH), R = CH), in the presence of trisborohydride RE(BH)(THF) (RE = Y and Nd) as a precursor and a base. The isolation of various molecular structures, nine of which were structurally characterized by X-ray diffraction analysis, was achieved and revealed to depend not only on (i) the nature of the 2-pyridinemethanamido ligand and (ii) the rare-earth element but also on (iii) the reaction conditions, notably the type of base used. These include seven mono-substituted species, eventually also comprising the cation derived from the base reagent, such as [(PyA1)Y(BH)][Mg(THF)] (1Y), [(PyA1)Nd(BH)Mg(PyA1)](THF) (1Nd), (PyA1)Nd(BH)(THF) (1'Nd), [(PyA1)Nd(THF)(BH)(μ-BH)] (1''Nd), [(PyA2)Nd(BH)][Mg(THF)] (3Nd), (PyA2)Nd(BH)(THF) (3'Nd) and (PyA3)Nd(BH) (4Nd), as well as two bis-substituted complexes (PyA1)Y(BH) (2Y) and (PyA1)Nd(BH) (2Nd).
View Article and Find Full Text PDFGenomic alterations of are common and associated with adverse clinical features in B-ALL. The relationship between the type of alteration, disease subtype and outcome are incompletely understood. Leukemia subtype and genomic alterations were determined using transcriptome and genomic sequencing and SNP microarray in 688 pediatric patients with B-ALL in St.
View Article and Find Full Text PDF